SCHEMBL4054887

SCHEMBL4054887

O=c1c2[nH]c(-c3ccc(S(=O)(=O)NCCc4cccnc4)cc3)cc2n(CC2CC2)c(=O)n1CC1CC1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 14/20 0.55
ADORA1 P30542 10/20 0.55
ADORA3 P0DMS8 9/20 0.55
ADORA2A P29274 5/20 0.47
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
LMNA P02545 1/20 0.42
POLB P06746 1/20 0.42
HPGD P15428 1/20 0.42
KMT2A Q03164 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
PCK1 P35558 1/20 0.40
TBXAS1 P24557 2/20 0.40
PDE5A O76074 1/20 0.39
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4229255 0.87 ADORA2B (0.72) ADORA2BADORA1ADORA3ADORA2AKMT2A
SCHEMBL4051486 0.81 ADORA2B (0.71) ADORA2BADORA1ADORA3ADORA2ALMNA
SCHEMBL4054039 0.81 ADORA2B (0.64) ADORA2BADORA1ADORA3ADORA2A
SCHEMBL4051673 0.81 ADORA2B (0.73) ADORA2BADORA1ADORA3ADORA2A
SCHEMBL4055594 0.80 ADORA2B (0.64) ADORA2BADORA1ADORA3ADORA2ALMNA
SCHEMBL4052706 0.76 ADORA2B (0.73) ADORA2BADORA1ADORA3ADORA2AMEN1
SCHEMBL4716534 0.75 ADORA2B (0.51) ADORA2BADORA1ADORA3ADORA2A
SCHEMBL4052045 0.74 ADORA2B (0.66) ADORA2BADORA1ADORA3ADORA2A
SCHEMBL4712380 0.74 ADORA2B (0.57) ADORA2BADORA1ADORA3ADORA2A
SCHEMBL4050484 0.74 ADORA2B (0.63) ADORA2BADORA1ADORA3ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7504398-B2 potent and selective antagonists of adenosine receptors; Parkinson's disease, asthma, allergies, inflammation, atherosclerosis, hypertension, gastrointestinal disorders, cell proliferation and autoimmune diseases; sulfonamidation LABORATORIOS ALMIRALL S.A. (ES) 2009-03-17 US disclosed
EP-1492793-B1 NEW-4-(PYRROLOPYRIMIDIN-6-YL)BENZENESULPHONAMIDE DERIVATIVES ALMIRALL LAB (ES) 2008-01-16 EP disclosed